Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases

Clinical trial NCT05414487 · UNKNOWN

Trial details

NCT number: NCT05414487
Sponsor: Tianjin Medical University General Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Multiple Sclerosis Neuromyelitis Optica Spectrum Disorder Demyelinating Diseases of the Central Nervous System

Start date: 2022-10-15
Primary completion: 2023-12-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.